Gilgamesh Pharmaceuticals Patents

Patent portfolio assigned to Gilgamesh Pharmaceuticals (verified via public assignee records). Estimated patent count: 5. US psychedelic-derived neuro/psychiatry biotech. Multiple patents/applications assigned to 'Gilgamesh Pharmaceuticals Inc' on Google Patents (US11440879B2, US20220409555A1, WO2021134086A1, etc.); count is an estimate of distinct families visible. AbbVie is a 2024 collaboration/option-to-license partner (not a customer).